Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia

Helicobacter

Volumn 16, Issue 2, 2011, Pages 107-112

  Tsukanov, Vladislav Vladimirovich ^a   Butorin, Nikolai Nikolaevich ^b   Maady, Ayas Sergeevich ^c   Shtygasheva, Olga Vladimirovna ^b   Amelchugova, Olga Sergeevna ^a   Tonkikh, Julia Leongardovna ^a   Fassan, Matteo ^d   Rugge, Massimo ^d  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b Khakass State University   (Russian Federation)

^c Tyva Republican Hospital   (Russian Federation)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

CagA; Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

IMMUNOGLOBULIN G; UREASE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MONGOLOID RACE; NONHUMAN; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER;

ADOLESCENT; ADULT; AGED; FEMALE; HELICOBACTER INFECTIONS; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; RUSSIA; SIBERIA; STOMACH NEOPLASMS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 79952730794     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00827.x     Document Type: Article

References (37)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467-77.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, Kuipers EJ. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007;56:1665-70.
4. Tsukanov VV, Barkalov SV, Tonkikh IL, Shtygasheva OV, Barmakov AE, Bronnikova EP, Amel'chugova OS. [Prevalence of Helicobacter pylori CaGa strains and peptic ulcer in the population of Eastern Siberia]. Ter Arkh 2007;79:15-8.
5. Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA, Bessonov PP, Vasil'ev RR, Tatarinova OV, Muchina EG. [Prevalence of atrophic gastritis in different populations in Siberia on medical evidence of the serological survey]. Klin Med (Mosk) 2008;86:35-8.
6. Schistosomes, liver flukes and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
8. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-72.
9. Correia M, Machado JC, Ristimaki A. Basic aspects of gastric cancer. Helicobacter 2009;14(Suppl 1):36-40.
10. Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol 2009;60:3-21.
11. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
12. Gatta L, Di Mario F, Vaira D, et al. Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant populations. Intern Emerg Med 2011;6:35-9.
13. Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci 2006;97:1129-38.
14. Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007;12(Suppl 1):1-3.
15. Shanks AM, El-Omar EM. Helicobacter pylori infection, host genetics and gastric cancer. J Dig Dis 2009;10:157-64.
16. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
17. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M. Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: a potential pathway to cancer? Helicobacter 2003;8:227-34.
18. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006;1:63-96.
19. Beswick EJ, Suarez G, Reyes VE. H pylori and host interactions that influence pathogenesis. World J Gastroenterol 2006;12:5599-605.
20. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008;134:306-23.
21. Bornschein J, Rokkas T, Selgrad M, Malfertheiner P. Helicobacter pylori and clinical aspects of gastric cancer. Helicobacter 2009;14(Suppl 1):41-5.
22. Izzotti A, Durando P, Ansaldi F, Gianiorio F, Pulliero A. Interaction between Helicobacter pylori, diet, and genetic polymorphisms as related to non-cancer diseases. Mutat Res 2009;667:142-57.
23. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010;23:713-39.
24. González CA, López-Carrillo L. Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 2010;45:6-14.
25. Nijevitch AA, Sataev VU, Alyangin VG, Khasanov RS, Mamleev IA. "De-Nol test" for rapid diagnosis of Helicobacter pylori in childhood. Acta Paediatr 1999;88:234-5.
26. Lapina TL. Main principles of Helicobacter pylori diagnostics. Russian J Gastroenterol Hepatol Coloproctol 1999;2:41-5.
27. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90.
28. Won HH, Kim JW, Kim MJ, Kim S, Park JH, Lee KA. Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians. Cytokine 2010;51:73-7.
29. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
30. Basso D, Zambon CF, Letley DP, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008;135:91-9.
31. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 2010;139:1894-901.
32. Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, Tompkins D, Axon A. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006;55:1545-52.
33. Aoki K, Kihaile PE, Wenyuan Z, Xianghang Z, Castro M, Disla M, Nyambo TB, Misumi J. Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 2005;15:598-606.
34. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
35. Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-8.
36. Graham DY, Rugge M. Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol 2010;44:167-72.
37. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, Basso D, Plebani M, Graham DY. Gastritis OLGA staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010;31:1104-11.